Detalhe da pesquisa
1.
Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome.
Cancer
; 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340331
2.
Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia.
Cancer
; 127(14): 2489-2499, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33793970
3.
Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia.
Am J Hematol
; 98(1): E11-E14, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35633516
4.
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia.
Clin Lymphoma Myeloma Leuk
; 24(4): e168-e173, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212207
5.
Incidence of adverse effects in patients receiving ponatinib with concomitant azole antifungals.
Leuk Lymphoma
; 64(1): 79-86, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36222579
6.
Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia.
Ther Adv Hematol
; 9(12): 347-356, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-33815734